Lipoprotein subfractions and particle sizes are increasingly used in observational studies to predict the risk of cardiovascular diseases. However, the causal role of the different subfractions remain largely uncertain because the conventional study designs are subject to unmeasured confounding. We used Mendelian randomization and public GWAS summary data to estimate the effect of 82 lipoprotein subfraction and particle size traits on the occurrence of coronary artery disease and myocardial infarction. We found that, unlike LDL and VLDL subfractions, HDL subfraction traits appear to have heterogeneous effects on coronary artery disease according to particle size. The concentration of medium HDL particles may have a protective effect on coronary artery disease that is independent of traditional lipid factors.
Introduction
Lipoprotein subfractions have been increasingly used in epidemiological studies and even in clinical practice to predict the risk of cardiovascular diseases (CVD) (1) (2) (3) . Some studies have identified potentially novel lipoprotein subfraction predictors for CVD (2, (4) (5) (6) (7) (8) and demonstrated that the addition of lipoprotein subfraction measures can significantly improve the prediction of CVD (1, (9) (10) (11) . However, observational studies of lipoprotein subfractions have provided conflicting evidence. For example, several studies have suggested that small, dense LDL particles are more atherogenic (4, 12) , while others have found that larger LDL size is associated with CVD risk (13, 14) . Several recent observational studies found that the inverse association of CVD outcomes with smaller HDL particles is stronger than the association with larger HDL particles (6, 11, 15, 16) , but studies in different cohorts have reached contradictory conclusions (17, 18) .
Currently, the utility of lipoprotein subfractions in routine clinical practice remains controversial (14, (19) (20) (21) , there is a lack of intervention data showing that changing specific subfractions reduces CVD risk (21), and there is uncertainty around the causal relationship of subfractions to CVD. Mendelian randomization (MR) is an epidemiological method to investigate the causal role of risk exposures (22) . MR uses genetic variation as instrumental variables (23) and asks if genetic predisposition to a higher level of the exposure (in this case, lipoprotein subfractions) is associated with higher occurrences of the disease outcome. A positive result suggests a causal relationship if the genetic variants satisfy the instrumental variable assumptions (23,24).
Because Mendelian randomization can potentially provide unbiased causal estimate even when there are unmeasured confounders, it is generally considered more credible than other non-randomized designs (25, 26) . MR has been used to estimate the association of several metabolites with CVD risk, although most prior studies are limited to one or a few risk exposures at a time (27, 28) . In this study we use MR to estimate the effect of 82 lipid and lipoprotein traits on the occurrence of coronary artery disease (CAD) and myocardial infarction (MI). This is to our knowledge the first comprehensive MR study to investigate the association of all lipoprotein subfractions with CAD.
In addition to complementing the existing observational epidemiology of lipoprotein subfractions, our study is also motivated by the inconclusive results about HDL-C in prior MR studies (29) (30) (31) (32) ). An MR study of HDL subfractions can thus provide additional insights into the heterogeneous MR estimates and strong genetic correlation between HDL-C and CAD (32,33) reported in previous studies. We will discuss interpretations of this study in the Discussion section.
Materials and Methods

Lipoprotein particle measurements
We used GWAS summary data of 82 lipid and lipoprotein traits reported by two previous studies (34, 35) . In both studies, the circulating lipid and lipoprotein traits are measured using high-throughput nuclear magnetic resonance (NMR) spectroscopy (36). All the subfraction traits are named using three components separated by hyphen: the first indicates the size (XS, S, M, L, XL, XXL); the second indicates the category according to the lipoprotein density (VLDL, LDL, IDL, HDL); the third indicates the measurement (C for total cholesterol, CE for cholesterol esters, FC for free cholesterol, L for total lipids, P for particle concentration, PL for phospholipids, TG for triglycerides). For example, M-HDL-P means the concentration of medium HDL particles. Apart from the traditional lipid traits (TG, LDL-C, HDL-C), the two studies also measured the average diameter of the fractions (VLDL-D, LDL-D, HDL-D) and the concentration of apoB and apoA1.
Mendelian randomization design
We employed a three-sample summary-data Mendelian randomization design in this study, in which one genome-wide association study (GWAS) was used to select independent SNPs that are associated with one or several lipoprotein measures. More specifically, the selection GWAS was used to create two sets of SNPs that are in linkage equilibrium in a reference panel (! " < 0.001): 1. a set of genome-wide significant SNPs (p-value ≤ 5 × 10 *+ ); 2. a full set of SNPs (p-value ≤ 1). The latter is called the "genome-wide Mendelian randomization" design and requires more advanced statistical methods to avoid weak instrument bias (32). The other two GWAS were then used to obtain summary associations of the selected SNPs with the exposure and the outcome, as in the commonly used two-sample MR design (37,38). To avoid the pitfall of statistical selection bias (aka winner's curse), we require that the other two GWAS used for estimation of causal effect to have non-overlapping sample set with the selection GWAS. More details about the three-sample Mendelian randomization design can be found elsewhere (32,39) and the Online Supplement. Table 1 describes all GWAS summary datasets used in the present study, including two GWAS of the traditional lipid traits (40,41), two recent GWAS of circulating metabolites using nuclear magnetic resonance spectroscopy (34, 35) , and three GWAS of coronary artery disease or myocardial infarction (42-44).
GWAS datasets and instrument selection
Based on how the genetic instruments were selected, the MR designs we used can be categorized into three types:
1. Traditional selection: Traditional lipid traits were used to select SNPs for the Mendelian randomization of lipoprotein subfraction traits. That is, HDL-C was used to select SNPs for HDL subfraction traits, LDL-C for IDL and LDL subfraction traits, and TG for VLDL subfraction traits. The selected SNPs were then used to estimate the univariate effect of lipoprotein subfractions on CAD. 2. Subfraction selection: For each lipoprotein subfraction, the instrumental SNPs were selected using the same or closest lipoprotein subfraction in the selection GWAS. For example, if the target exposure is S-HDL-L but this is not measured in the selection GWAS, we use S-HDL-P in the selection GWAS. The selected SNPs are then used to estimate the univariate effects. Because we have two GWAS datasets for the lipoprotein subfractions, we used one for instrument selection and the other one for statistical inference and then swapped their roles. 3. Multivariate Mendelian randomization: In this design, the estimate of each lipoprotein subfraction was further adjusted for the traditional lipid traits (TG, LDL-C, HDL-C) of the other two lipoprotein classes (TG is treated as a traditional lipid trait of VLDL and IDL traits are treated as belonging to the LDL class). For example, M-HDL-P is further adjusted for LDL-C and TG; IDL-C and L-LDL-C are further adjusted for HDL-C and TG; S-VLDL-CE is further adjusted for HDL-C and LDL-C. In this multivariate MR, SNPs were selected as instruments if they were associated (pvalue ≤ 10 *, ) with at least one of the three exposures (the subfraction trait under investigation and two other traditional lipids).
Statistical methods
For univariate MR (the first two types of instrument selection), we used three statistical methods: inverse-variance weighting (IVW) (45), weighted median (46), and robust adjusted profile score (RAPS) (32,47). All three methods require the exposure GWAS and outcome GWAS have non-overlapping samples. The last two methods can provide consistent estimate of the causal effect even when some of the genetic variants are not valid instruments, provided that the direct effects of the genetic variants are independent of the strength of their associations with the exposure (32,47). The last condition is called the Instrument Strength Independent of Direct Effect (InSIDE) assumption in the literature (46, 48) . RAPS is also robust to idiosyncratically large direct effects by using techniques from robust statistics (47). RAPS further increases the statistical power by exploiting weak genetic instruments and does not suffer from weak instrument bias (32). Because IVW and weighted median can be severely biased when there are many SNPs only weakly associated with the exposure (32,47), we only used them with the set of genome-wide significant SNPs.
For multivariate Mendelian randomization, we used an extension of RAPS called GRAPPLE (Genomewide mendelian Randomization under Pervasive PLEiotropy) to obtain the statistical estimates (39). This method allows overlapping exposure and outcome GWAS.
We used Bonferroni's correction to adjust for multiple comparisons. In our main analysis using RAPS, we used 7 designs to investigate 82 lipoprotein traits, so the p-value threshold for significance level 0.05 is 0.05/7/82 = 8.7 × 10 *. .
Genetic correlations
Genetic correlation is a measure of association between the genetic determinants of two phenotypes. It is generally different from the epidemiological correlation estimated from cross-sectional data. To further explore whether any novel causal effect found by Mendelian randomization is independent of other subfraction exposures, we used the LD-score regression to estimate the genetic correlations of the lipoprotein subfraction traits (49). The two GWAS datasets of lipoprotein subfractions are used to obtain two independent estimates of the genetic correlations and are then combined using inverse-variance weighted average.
Mendelian randomization
The estimated associations of genetic determinants of selected lipoprotein subfractions with CAD or MI are reported in Table 2 and Figure 1Error ! Reference source not found.. The full results are available in the Online Supplement.
Associations of genetically-determined apoB-containing lipoproteins with CAD/MI
As expected, in all MR analyses (univariate and multivariate), genetically-determined LDL-C, apoB and TG had strong positive association with CAD and MI ( Table 2 ) and most of the results are statistically significant after Bonferroni's correction.
In univariate MR, genetically-determined VLDL and LDL subfractions had uniformly positive associations with CAD and MI. Within VLDL or LDL, the magnitude of the associations was very similar, though the associations of VLDL subfractions were smaller than of LDL subfractions. Most of the results were statistically significant after Bonferroni's correction for LDL subfractions, and only some were significant for VLDL subfractions. In multivariate MR that adjusted for LDL-C and TG, the associations of VLDL subfractions were attenuated and became non-significant. In contrast, after adjusting for HDL-C and TG, the associations of LDL subfractions were still strong and statistically significant.
Genetically-determined VLDL particle size (VLDL-D) showed weak negative associations with CAD and MI in univariate and multivariate MR. The associations are not statistically significant after adjusting for multiple comparisons. In comparison, genetically-determined LDL size (LDL-D) showed positive associations with CAD and in one study the association is statistically significant after Bonferroni's correction.
Associations of genetically-determined HDL measures and HDL subfractions with CAD/MI
In one univariate MR study, genetically-determined HDL-C showed significant association with CAD, but the diagnostic plot show evidence of horizontal pleiotropy that violates the InSIDE assumption (Supplement Figure F6 ). The magnitude of this association was much smaller than that of LDL-C or TG. In all other univariate and multivariate MR studies, HDL-C was not associated with CAD or MI. Geneticallydetermined apoA1, the major protein component of HDL particles, did not show a significant association with CAD or MI.
In contrast to the apoB lipoproteins, genetically-determined HDL subfractions showed highly heterogeneous associations with CAD and MI in univariate MR. The concentration and lipid contents of extra-large HDL particles were not associated with CAD or MI. The large HDL traits trended toward a negative association with CAD, but the associations were non-significant after Bonferroni's correction and were attenuated in multivariate MR. In contrast, the medium HDL traits (M-HDL-P, M-HDL-C, M-HDL-L) had inverse associations with CAD that remained statistically significant after adjusting for multiple comparisons. Among the small HDL traits, S-HDL-P and S-HDL-L had a trend toward inverse associations with CAD but were not statistically significant. Interestingly, S-HDL-TG had significantly positive association with CAD, possibly confounded by its strong genetic correlation with VLDL subfractions ( Figure 2 ) that had similar positive associations with CAD.
Adjusting for LDL-C and TG in the multivariate MR did not change the results for HDL subfractions substantially. In particular, the inverse association between medium HDL traits and CAD were not attenuated but did become non-significant due to increased standard error.
Finally, genetically-determined HDL particle size (HDL-D) was not associated with CAD or MI.
Horizontal pleiotropy for M-HDL-P
We further evaluate the independence of M-HDL-P as a risk factor for CAD. By a meta-analysis (inversevariance weighting) of the two GWAS of lipoprotein subfractions (34,35), we obtained 10 SNPs that are significantly associated with M-HDL-P (p-value ≤ 5 × 10 *+ ). Table 1 lists the associations of these 10 SNPs with HDL subfractions, HDL-C, LDL-C, TG and CAD. Although M-HDL-P was not genetically correlated with LDL-C or TG ( Figure 2 ), several SNPs associated with M-HDL-P were also associated with LDL-C and/or TG, so there is potentially a large amount of horizontal pleiotropy in the univariate Mendelian randomization analysis of M-HDL-P. However, the associations of these 10 SNPs with LDL-C and TG did not exhibit any apparent pattern and are roughly balanced around the null. Therefore we did not find any evidence against the InSIDE condition, a crucial assumption for the validity of the weighted median and RAPS estimators (46,47). This observation is further illustrated in Figure 3 , in which the SNP effects on CAD are plotted against the SNP effects on M-HDL-P. Figure 3 also demonstrates how adjusting for LDL-C and TG (red arrows) may affect the multivariate Mendelian randomization (adjusted effect on CAD = original effect on CAD -0.45 * effect on LDL-C -0.25 * effect on TG). After the adjustment, the associations of the genetic variants with CAD generally became closer to the straight line in red which corresponds to a Mendelian randomization estimate of -0.3.
Discussion
Because existing GWAS data for lipoprotein subfractions are much smaller than those for the traditional lipid traits, there are fewer genetic variants significantly associated with the subfraction traits. This limits the statistical power of a conventional MR analysis. We overcome this challenge by adopting a new statistical method, robust adjusted profile score (RAPS), that efficiently utilizes weak instruments (32, 47) . RAPS is also robust to certain violations of the instrumental variable assumptions, including horizontal pleiotropy that satisfies the InSIDE assumption. These methodological innovations allow us to obtain new insights into the role of lipoprotein subfractions.
Our study provides a comprehensive Mendelian randomization examination of the potential causal role of lipoprotein subfractions in CAD. To summarize, our results suggest that:
• LDL and VLDL subfractions appear to have nearly uniform effects on CAD across particle size.
Therefore, the results do not support the hypothesis that small, dense LDL particles are more atherogenic. On the contrary, we found some evidence that larger LDL particle size might have positive effect on CAD. • HDL subfractions appear to have heterogeneous effects on CAD. In particular, the concentration and lipid constituents of medium HDL particles appear to have a protective effect on CAD occurrence. Moreover, this relationship is independent of traditional risk factors in the following sense:
o M-HDL-P was not genetically correlated with the traditional lipid traits (HDL-C, LDL-C and TG). o The estimated effect of M-HDL-P (and other lipid measurements such as M-HDL-C) with CAD was not attenuated when adjusting for LDL-C and TG in multivariate MR analysis, although the effect became statistically non-significant after adjusting for multiple comparisons. o The SNPs that are associated with M-HDL-P showed a balanced pattern of association with LDL-C and TG, which is consistent with the InSIDE assumption.
We investigated the effect of lipoprotein subfractions on CAD using multiple datasets, study designs and statistical methods. The MR estimates are overwhelming in agreement, which further strengthens our conclusions.
There has been a heated debate on the role of HDL in preventing CVD in recent years following the failure of several CETP trials (50-52). Observational epidemiology studies have long demonstrated strong inverse association between HDL-C and the risk of CAD or MI (53-55), but contradictory evidence was found in MR studies. In an influential study, Voight and collaborators found that genetic variants associated with HDL-C had varied associations with CAD and that all variants suggesting a significant protective effect of HDL-C on CAD also had pleiotropic effects on LDL cholesterol (LDL-C) or triglycerides (TG) (29). One single nucleotide polymorphism (SNP) in the HNF4A gene, when used as an instrumental variable, even suggested positive association of HDL-C with CAD. Another MR study found that HDL-C is negatively associated with CAD using 48 SNPs as instruments, but the association became statistically non-significant after restricting to the 19 SNPs that do not have pleiotropic association with LDL-C or TG (56). A similar finding was made in a subsequent study (31), where the negative effect of HDL-C on CAD found by conventional MR methods becomes statistically non-significant after using the "pleiotropyrobust" MR-Egger regression (48). A more recent study using the more powerful MR-RAPS found that the negative effect of HDL-C is statistically significant, although estimates of the magnitude of effect depend considerably on the strength of the instruments (32). To summarize, the failed CETP trials and previous MR studies have led to the broad conclusion that raising HDL-C may not causally reduce the risk of CAD, at least not in a uniform way. Our results for the HDL subfractions further support this conclusion, as their effects on CAD appear to be heterogeneous.
Our results may also be related to the HDL function hypothesis (57). Cholesterol efflux capacity, a measure of HDL function, has been documented as superior to HDL-C in predicting CVD risk (58,59). Recent epidemiologic studies found that HDL particle size is positively associated with cholesterol efflux capacity in post-menopausal women (60) and in an asymptomatic older cohort (61). However, mechanistic efflux studies showed that small HDL particles actually mediate more cholesterol efflux (62,63). A likely explanation of this seeming contradiction is that high concentrations of small HDL particles in the serum may mark a block in maturation of small HDL particles (61). This may also explain our finding that only the medium HDL traits have significant negative association with CAD in Mendelian randomization, as increased medium HDL may mark successful maturation of small HDL particles.
Our study should be viewed in the context of its limitations, in particular, the inherent limitations of the summary-data Mendelian randomization design. Any causal inference from non-experimental data makes unverifiable assumptions, so does our study. Conventional MR studies assume the genetic variants are valid instrumental variables. The statistical methods we used, in particular MR-RAPS, make less stringent assumption---the causal inference is unbiased if, apart from a few instruments, most of the pleotropic effects satisfy the InSIDE assumption (47,48). The InSIDE assumption is unverifiable (64) but can be falsified (32). Figure 3 and scatterplots in the Online Supplement do not suggest evidence against the InSIDE assumption for medium HDL traits, but this does not completely eliminate the possibility that InSIDE is violated.
Our study did not adjust for other important risk factors such as body mass index, blood pressure, and smoking. Heterogeneous populations are used to obtain genetic associations with the exposures and the outcomes, which may introduce bias (65). Most of the genes strongly associated with the concentration of medium HDL particles are also associated with LDL-C and/or TG ( Table 3 ). Although this does not necessarily bias the MR estimate (Figure 3 ), the lack of genetic variants exclusively associated with medium HDL particles means that medium HDL particles may only be a biomarker (instead of the causal mediator) in a mechanism that lowers CAD risk. 
A Methods
A.1 Study design
A.1.1 Univeraite Mendelian randomization
For univariate Mendelian randomization we follow the three-sample summary-data design as described in [5] . This design requires three non-overlapping GWAS summary datasets which will be referred to as the selection, exposure, and outcome datasets. The selection and exposure datasets are two non-overlapping GWAS for the same (or similar) phenotypes. After obtaining the GWAS summary datasets, we preprocessed the data to select genetic instruments for the statistical analysis. We first removed SNPs that do not coappear in all three datasets. Then we used the remaining selection dataset to find independent SNPs (distance ≥ 10 megabase pairs, linkage disequilibrium r 2 ≤ 0.001) that are most associated with the exposure phenotype. This was done in a greedy fashion using the linkage-disequilibrium (LD) clumping function in the PLINK software [3] . We created two sets of SNPs, one set with genome-wide significant association (p-value ≤ 5 × 10 −8 ) in the selection dataset, and one set without any restriction on the p-value. For this study, the former set usually consisted of a few (if the selection dataset is Kettunen or Davis) to a few dozen (if the selection dataset is GERA) SNPs, while the latter set typically contained about 1000 independent SNPs across the entire genome. We then obtained the associations of these selected SNPs with the exposure (some lipoprotein subfraction trait) and the outcome (CAD or MI) using the other two GWAS summary datasets.
Because we had multiple GWAS datasets for the lipoprotein subfractions and CAD/MI (Table 1) , whenever possible we swapped the role of each GWAS in the three-sample Mendelian randomization design to obtain multiple statistical estimates. In total we conducted five different univariate Mendelian randomization studies which are summarized in Table A1 . Some of the Mendelian randomization results (selected designs and phenotypes) are reported in the main paper. The full results are reported in Supplement D below. • Both traditional lipid traits and subclass trait were used in the SNP selection. For example, in the multivariate Mendelian randomization study of M-HDL-P, the Davis GWAS (for M-HDL-P) and GERA GWAS (for HDL-C, LDL-C, TG) were used to select SNPs. Significance of each SNP was defined as the smallest of its four p-values (with M-HDL-P, HDL-C, LDL-C, TG), which were used as input to LD-clumping to select independent SNPs. For each lipoprotein subclass, we created one set of SNPs whose smallest p-value is less than 10 −4 .
• The SNP-exposure association is now a vector of length 4 (instead of a scalar), containing its associations with the lipoprotein subclass under study (for example M-HDL-P) and HDL-C, LDL-C, TG.
• We no longer require the selection, exposure, outcome datasets to be completely non-overlapping. More specifically, we still require the selection dataset (in our 1st multivariate MR study, GERA and Davis) to be independent of the other datasets (GLGC, Kettunen, CARDIoGRAM, UK Biobank), but we don't require the exposure (GLGC + Kettunen) and outcome (CAD + UK Biobank) datasets to be non-overlapping. This means that the SNP-exposure and SNP-outcome associations are not independent because some samples are used to compute both associations. Fortunately, (author?) [4] shows that the correlation between the SNPexposure and SNP-outcome marginal effect estimates does not depend on the SNPs and can be estimated using the GWAS summary data.
A.2 Statistical methods
For univariate Mendelian randomization, we applied three statistical methods: inverse-variance weighting (IVW), weighted median, and robust adjusted profile score (RAPS). For IVW and weighted median we used the implementation in the TwoSampleMR software package in R [2] . Because IVW and weighted median estimates are biased towards 0 when there are weak instruments [1, 6] , we only use these methods with the set of SNPs that are genome-wide significant in the selection dataset. For RAPS we used the implementastion in the mr.raps package (https://github.com/qingyuanzhao/mr.raps), using the empirical partially Bayes estimator with Huber's loss function as described in [5] . RAPS does not suffer from weak instrument bias as long as the average instrument strength is not too weak [6] , so we applied RAPS to both sets of SNPs. For multivariate Mendelian randomization, we applied the multivariate extension to RAPS (aka GRAPPLE) that is briefly described below. For SNP j, we assume the estimated association with the K exposuresγ j ∈ R K and the outcomeΓ j follow a multivariate normal distribution:
where the mean vector (Γ j , γ j ) is unknown, the diagonal matrix S j contains the standard errors of the GWAS summary coefficients, and Σ is the correlation matrix due to sample-overlap of the GWAS that is shared between the SNPs. The setting considered in [6] assuming no sample overlap is a special case of this model with K = 1 and Σ = I 2 . In the more general setting, we estimate Σ using sample correlation of the GWAS coefficients for the non-significant SNPs (e.g. p-value ≥ 0.5 in the selection GWAS). Let the estimate beΣ. We further assume the causal effect β (a vector because we have multiple exposures) satisfies the InSIDE assumption, α j = Γ j −γ T j β ⊥ γ j , for most SNPs j. The direct effect α j is assumed to satisfy a random effects model, α j ∼ N(0, τ 2 ).
To estimate the causasl effect β, define
where Σ Xj is the variance ofγ j and Σ Xj Yj is the covariance betweenγ j andΓ j in our model, replacing Σ withΣ. The GRAPPLE estimates β and τ 2 by solving the following estimating equations:
where ρ is some robust loss function (we used Huber's loss function) and δ = E[ρ(Z)] for Z ∼ N(0, 1). Standard errors for β and τ 2 are computed using the delta method. More details about GRAPPLE can be found in a forthcoming paper [4] .
A.3 Lipid and lipoprotein traits
A full list of lipid and lipoprotein traits used in this study can be found in Table A2 . ? ?
? ?
? 
D Full Mendelian randomization results
See Tables D5 to D7 below. Red indicates p-value is significant (at level 0.05) after Bonferroni correction for all the results in the corresponding table and blue indicates p-value ≤ 0.05 
